On Friday, April 1, Senator Thom Tillis (R–NC) wrote to the Food and Drug Administration (FDA) and the U.S. Patent and Trademark Office (USPTO) to …
Full story here.
Published by www.ipwatchdog.com
Visited 1 times, 1 visit(s) today
April 5, 2022• byQuorum Call
On Friday, April 1, Senator Thom Tillis (R–NC) wrote to the Food and Drug Administration (FDA) and the U.S. Patent and Trademark Office (USPTO) to …